Coforge working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

72.84×	72.84×	66.35×	67.94×	68.37×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
27,748.42×	27,748.42×	32,425.37×	28,235.08×	4,186.90×
−27,675.58×	−27,675.58×	−32,359.02×	−28,167.14×	−4,118.53×
7.24×	7.33×	7.47×	8.57×	9.00×
1.20×	1.20×	1.30×	1.56×	1.51×
1.03×	1.03×	1.32×	1.08×	1.28×
0.61×	0.61×	0.73×	0.63×	0.74×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

COFORGE₹1,962.00

Coforge Ltd.

· Technology

₹ CrorePeersPERSISTENT MPHASIS OFSS KPITTECH TATAELXSI LTM WIPRO TECHMMcap ₹65,923 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Receivable Days (DSO)	68.37	67.94	66.35	72.84	72.84
Payable Days (DPO)	4,186.90	28,235.08	32,425.37	27,748.42	27,748.42
Cash Conversion Cycle (days)	-4,118.53	-28,167.14	-32,359.02	-27,675.58	-27,675.58
Working Capital Turnover	9.00	8.57	7.47	7.33	7.24
Asset Turnover	1.51	1.56	1.30	1.20	1.20
Cash Conversion (CFO/Net Income)	1.28	1.08	1.32	1.03	1.03
CFO/EBITDA	0.74	0.63	0.73	0.61	0.61

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.